Electronic book text
February 15, 2007
9780801892097
9780801884771
English
336
10
3
9.00 Inches (US)
6.00 Inches (US)
$29.00 USD, £21.50 GBP
v2.1 Reference
Paperback / softback
December 15, 2008
9780801891007
English
336
10
3
9.00 Inches (US)
6.00 Inches (US)
0.87 Inches (US)
1 Pounds (US)
$29.00 USD, £21.50 GBP
v2.1 Reference

Prescribing by Numbers

Drugs and the Definition of Disease

Winner, 2009 Rachel Carson Prize, Society for the Social Studies of Science

Winner, 2012 Edward Kremers Award, American Institute of the History of Pharmacy

The second half of the twentieth century witnessed the emergence of a new model of chronic disease—diagnosed on the basis of numerical deviations rather than symptoms and treated on a preventive basis before any overt signs of illness develop—that arose in concert with a set of safe, effective, and highly marketable prescription drugs. In Prescribing by Numbers, physician-historian Jeremy A. Greene examines the mechanisms by which drugs and chronic disease categories define one another within medical research, clinical practice, and pharmaceutical marketing, and he explores how this interaction has profoundly altered the experience, politics, ethics, and economy of health in late-twentieth-century America.

Prescribing by Numbers highlights the complex historical role of pharmaceuticals in the transformation of disease categories. Greene narrates the expanding definition of the three principal cardiovascular risk factors—hypertension, diabetes, and high cholesterol—each intersecting with the career of a particular pharmaceutical agent. Drawing on documents from corporate archives and contemporary pharmaceutical marketing literature in concert with the clinical literature and the records of researchers, clinicians, and public health advocates, Greene produces a fascinating account of the expansion of the pharmaceutical treatment of chronic disease over the past fifty years.

While acknowledging the influence of pharmaceutical marketing on physicians, Greene avoids demonizing drug companies. Rather, his provocative and comprehensive analysis sheds light on the increasing presence of the subjectively healthy but highly medicated individual in the American medical landscape, suggesting how historical analysis can help to address the problems inherent in the program of pharmaceutical prevention.

About the Author

Jeremy A. Greene is an associate professor of medicine and the Elizabeth Treide and A. McGehee Harvey Chair in the history of medicine at Johns Hopkins University School of Medicine. He is the author of Generic: The Unbranding of Modern Medicine and coeditor of Prescribed: Writing, Filling, Using, and Abusing the Prescription in Modern America, both published by Johns Hopkins.

Reviews

"Greene provides suggestions on how to address some of the problems inherent in medical prevention."

- Choice

"Shows how the process of defining disease 'illustrates the porous relationship between the science and the marketing of health care.'"

- Nina C. Ayub - Chronicle of Higher Education

"A gripping story... Greene warns us in his superb book that things are not always as they are claimed."

- Howard Spiro - Yale Journal for Humanities in Medicine

"This is, I believe, one of the best, and most significant, books published recently on the development of medical practice and the pharmaceutical industry in the USA in the second half of the twentieth century."

- Judy Slinn - Social History of Medicine

"Greene focuses on the question of how public health priorities became closely aligned with the pharmaceutical industry's marketing practices... Offers a nuanced description of the development of 'therapeutics of risk reduction' with multiple lines of influence, subtle power shifts, and gains and losses for patients and physicians."

- Arthur Daemmrich - Chemical Heritage

"Greene describes the relationship between advances in treatment, the incentives of manufacturers, and the effect on the public of increased attention to prevention... The risk-benefit trade-offs of the quantitative approach are complex, and Greene's historical revelations are timely."

- Kevin A. Schulman, M.D. - New England Journal of Medicine

"The interaction between medical science and industry has been fruitfully explored by several excellent historians... but Greene's intricate narratives extend their work."

- Marcia Meldrum - Isis

"I heartily recommend this book."

- Toine Pieters - Medical History

"By the end of Prescribing by Numbers, one realizes it is an excellent book to think with. Greene uses his case studies to juxtapose the therapeutics of risk with more contemporary health dilemmas."

- Gregory J. Higby - Pharmacy in History

"Greene's nuanced and lucid research yields new insight into the mechanisms that linked specific medications to the management of particular chronic diseases in the postwar era."

- Cynthia A. Connolly, PhD, RN - Nursing History Review

Endorsements

"An insightful, engrossing exploration of how our notions of 'disease' have evolved—with profound implications for understanding the health care of today and tomorrow."

- Jerry Avorn, M.D, Professor of Medicine, Harvard Medical School, author of Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs

"What is remarkable about this book is not just the grace and assurance of Greene's writing, but the way Greene combines an insider's view of medical practice and pharmaceutical marketing with much broader social currents. It is an extraordinarily impressive work of scholarship."

- Carl Elliott, M.D., Ph.D., University of Minnesota Center for Bioethics, author of Better than Well: American Medicine Meets the American Dream

"Greene’s historical account of our brave new world of drug-driven risk reduction is troubling and calls for some response. Both the scholarly depth and balanced tone of Prescribing by Numbers suggests that rather than simply rooting out bad actors and unethical practices, we must grapple with the very values and structural forces that are central to medical care and health today."

- Robert Aronowitz, M.D., History and Sociology of Science Department, University of Pennsylvania
Johns Hopkins University Press
From 17

9780801891007 : prescribing-by-numbers-greene
Paperback / softback
336 Pages
$29.00 USD
9780801892097 : prescribing-by-numbers-greene
Electronic book text
336 Pages
$29.00 USD

Other Titles by Jeremy A. Greene

Generic

Jeremy A. Greene - with a new preface
Sep 2016 - Johns Hopkins University Press
$29.95 USD - Hardback
$24.95 USD - Electronic book text
$24.95 USD - Paperback / softback

Prescribed

edited by Jeremy A. Greene and Elizabeth Siegel Watkins
May 2012 - Johns Hopkins University Press
$68.00 USD - Hardback
$33.00 USD - Paperback / softback
$33.00 USD - Electronic book text

Other Titles in MEDICAL / History

Pseudo-Science and Society in 19th-Century America

edited by Arthur Wrobel
Oct 2021 - University Press of Kentucky
$45.00 USD - Paperback / softback
$45.00 USD - Electronic book text

Getting Under Our Skin

Lisa T. Sarasohn
Sep 2021 - Johns Hopkins University Press
$30.00 USD - Hardback
$30.00 USD - Electronic book text

Women Healers and Physicians

edited by Lilian R. Furst
Sep 2021 - University Press of Kentucky
$35.00 USD - Paperback / softback
$35.00 USD - Electronic book text

Other Titles in History of medicine

Getting Under Our Skin

Lisa T. Sarasohn
Sep 2021 - Johns Hopkins University Press
$30.00 USD - Hardback
$30.00 USD - Electronic book text

DSM

Allan V. Horwitz
Aug 2021 - Johns Hopkins University Press
$35.00 USD - Hardback
$35.00 USD - Electronic book text

Bodies in Doubt, second edition

Elizabeth Reis
Jul 2021 - Johns Hopkins University Press
$30.00 USD - Paperback / softback
$30.00 USD - Electronic book text